Quick Answer
RESMED INC reported Gross Profit of $3.05 billion for the year ending 2025.
- RESMED INC showed an increase of +15.1% in Gross Profit from 2024 to 2025.
- This data is from RESMED INC's annual report (Form 10-K), filed with the SEC on August 8, 2025.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2009: $150.18 million | Q4 2009: $164.21 million | Q1 2010: $166.58 million | Q3 2010: $173.95 million | Q4 2010: $186.00 million | Q1 2011: $182.50 million | Q3 2011: $185.05 million | Q4 2011: $198.72 million | Q1 2012: $210.50 million | Q3 2012: $208.65 million | Q4 2012: $232.71 million | Q1 2013: $239.45 million | Q3 2013: $227.98 million | Q4 2013: $248.76 million | Q1 2014: $251.79 million | Q3 2014: $237.31 million | Q4 2014: $263.22 million | Q1 2015: $251.43 million | Q3 2015: $238.62 million | Q4 2015: $266.51 million | Q1 2016: $259.88 million | Q3 2016: $269.18 million | Q4 2016: $309.07 million | Q1 2017: $299.71 million | Q3 2017: $305.61 million | Q4 2017: $349.79 million | Q1 2018: $344.30 million | Q3 2018: $343.09 million | Q4 2018: $374.53 million | Q1 2019: $380.97 million | Q3 2019: $391.62 million | Q4 2019: $427.13 million | Q1 2020: $449.66 million | Q3 2020: $438.66 million | Q4 2020: $462.48 million | Q1 2021: $447.26 million | Q3 2021: $506.29 million | Q4 2021: $504.32 million | Q1 2022: $491.20 million | Q3 2022: $540.81 million | Q4 2022: $579.72 million | Q1 2023: $617.75 million | Q3 2023: $600.06 million | Q4 2023: $646.93 million | Q1 2024: $692.78 million | Q3 2024: $717.22 million | Q4 2024: $751.28 million | Q1 2025: $766.41 million | Q3 2025: $820.82 million | Q4 2025: $878.72 million.
- Over the full 17 years of available data (2009 to 2025), RESMED INC's Gross Profit has grown by 451.6%.
- Historical annual values: Fiscal year 2025: $3.05 billion | Fiscal year 2024: $2.66 billion | Fiscal year 2023: $2.36 billion | Fiscal year 2022: $2.02 billion | Fiscal year 2021: $1.84 billion | Fiscal year 2020: $1.72 billion | Fiscal year 2019: $1.49 billion | Fiscal year 2018: $1.33 billion | Fiscal year 2017: $1.20 billion | Fiscal year 2016: $1.07 billion | Fiscal year 2015: $1.01 billion | Fiscal year 2014: $989.79 million | Fiscal year 2013: $940.66 million | Fiscal year 2012: $820.74 million | Fiscal year 2011: $741.33 million | Fiscal year 2010: $655.48 million | Fiscal year 2009: $553.80 million.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: